Implementation of new tests and treatments for patients with advanced triple negative breast cancer in routine care - data from the registry platform OPAL

被引：0
|
作者：
Zahn, M. -O [1 ]
Welt, A. [2 ]
Thill, M. [3 ]
Stickeler, E. [4 ]
Zaiss, M. [5 ]
Nusch, A. [6 ]
Engel, E. [7 ]
Chiabudini, M. [8 ]
Kruggel, L. [8 ]
Jaenicke, M. [8 ]
Marschner, N. [5 ]
Woeckel, A. [9 ]
Harbeck, N. [10 ]
Decker, T. [11 ]
机构：
[1] Uberortliche Berufsausubungsgemeinschaft MVZ Onko, Goslar, Germany
[2] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[3] Agaples Markus Krankenhaus, Klin Gynakol & Gynakol Onkol, Frankfurt, Germany
[4] Uniklin RWTH Aachen, Gynakol & Geburtsmed, Aachen, Germany
[5] Praxis Interdisziplinare Onkol & Hamatol, Freiburg, Germany
[6] Praxis Hamatol & Internist Onkol, Ratingen, Germany
[7] Hamatol Onkol Praxis Altona HOPA, Hamburg, Germany
[8] IOMEDICO, Freiburg, Germany
[9] Univ Klinikum Wurzburg, Frauenklin & Poliklin, Wurzburg, Germany
[10] Klinikum Univ Munchen, Frauenklin, Brustzentrum Innenstadt, Munich, Germany
[11] Studienzentrum Onkol Ravensburg Prof Dr Dechow, Dr Nonnenbroich GbR, Ravensburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ep110
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [31] Routine care and outcome of patients with locally advanced, inoperable (LAPC) and metastatic (MPC) pancreatic carcinoma Data from the Tumor Registry Pancreatic Cancer (TPK)
    Potthoff, K.
    Hegewisch-Becker, S.
    von der Heyde, E.
    Heinemann, V
    Hof, A.
    Binninger, A.
    Glasstetter, M.
    Jaenicke, M.
    Buerkle, D.
    Doerfel, S.
    Mohm, J.
    Marschner, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 241 - 241
  • [32] Prognostic factors and survival outcome in triple negative breast cancer patients in routine clinical practice in Slovenia
    Ovcaricek, T.
    Matos, E.
    Ravnik, M.
    Frkovic, S. Grazio
    Mozina, B.
    Borsnar, S.
    EJC SUPPLEMENTS, 2010, 8 (03): : 70 - 70
  • [33] 1L maintenance therapy in patients with newly diagnosed advanced or metastatic ovarian cancer in routine care in Germany: results from the German registry platform SMARAGD
    Juhasz-Boess, I.
    Nusch, A.
    Zaiss, M.
    Fuchs, R.
    Mueller, A.
    Jaenicke, M.
    Winter, S.
    Lennartz, C.
    Vahtrik, O.
    Marschner, N.
    Stickeler, E.
    Welt, A.
    Watermann, D.
    Woeckel, A.
    Decker, T.
    Gratzke, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 152 - 153
  • [34] Strategies to Enact for Equitable and Unbiased Care of Black, Triple Negative Breast Cancer Patients
    Leach, Virginia
    Regnante, Jeanne
    Karmo, Maimah
    Cooper, Shanda
    Peoples, Krista
    Wittig, Lizzie
    CANCER RESEARCH, 2024, 84 (09)
  • [35] Patterns of recurrence in triple negative breast cancer patients (automated IHC) : An Indian Tertiary Care Center data.
    Ghosh, Joydeep
    Agarwal, Sanjit
    Ganguly, Sandip
    Dabkara, Deepak
    Biswas, Bivas
    Nandi, Shibarati
    Chakraborty, Santam
    Datta, Soumitra
    Ahmed, Rosina
    Chatterjee, Sanjoy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] 6 Assessment of Radiation Trends in a Prospective Registry of Node Positive Patients With Triple Negative Breast Cancer
    Mitchell, M. P.
    Lehn, C.
    Wang, A.
    Sharma, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E37 - E37
  • [37] Treatment strategies for advanced triple negative breast cancer patients as per routine clinical practice: analysis from the observational study GEICAM/2014-03 (RegistEM)
    Novoa, Silvia Antolin
    Rodriguez, Cesar A.
    Cruz, Josefina
    Lopez-Tarruella, Sara
    Tibau, Ariadna
    Adrover, Encarna
    Miguel, Ana
    Margeli, Mireia
    Martinez, Purificacion
    Hernandez, Maria
    Anton, Antonio
    Rodriguez-Lescure, Alvaro
    Falo, Catalina
    Alvarez, Isabel
    Malon, Diego
    Andres, Raquel
    Alonso-Romero, Jose L.
    Gomez, Cesar
    Illaramendi, J. Jose
    Campo, Ruth
    Miralles, Juan Jose
    Bezares, Susana
    Rojo, Federico
    Guerrero-Zotano, Angel
    CANCER RESEARCH, 2023, 83 (05)
  • [38] Safety and efficacy of eribulin in combination with gemcitabine in patients with advanced triple negative breast cancer.
    Michalaki, Vasiliki
    Fragulidis, Georgios
    Kondis, Ioannis
    Karvouni, Eleni
    Dafnios, Nikolaos
    Kotsiou, Antonia
    Vassiliou, Ioannis
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [39] NICE allows immunotherapy treatment for small group of patients with advanced triple negative breast cancer
    Wise, Jacqui
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 377 : o1311
  • [40] TORCHLIGHT trial, brightening the life of more patients with advanced triple-negative breast cancer
    Zhang, Huiqiang
    Jin, Xiao
    Bian, Li
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
12345